Hiroyuki Nagashima

机构：National Institutes of Health, Maebashi Institute of Technology, Tohoku University, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Hospital Organization Hokkaido Medical Center, Hokkaido Science Education Center, Sapporo National Hospital, Japan Cancer Society · ORCID：0000-0001-8405-6746

发表论文 220 篇 · 总被引 2553 次 · h-index 26

代表论文

• Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cells (2025 · Cell · 被引 18)
• A dual role of Cohesin in DNA DSB repair (2025 · Nature Communications · 被引 16)
• Remodeling of Il4-Il13-Il5 locus underlies selective gene expression (2024 · Nature Immunology · 被引 15)
• Naturally arising memory-phenotype CD4 + T lymphocytes contain an undifferentiated population that can generate T H 1, T H 17, and T reg cells (2024 · Science Advances · 被引 6)
• Surgical Intervention After Zolbetuximab-Based Chemotherapy for CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A Case Series (2026 · Journal of Gastrointestinal Cancer · 被引 1)
• A PI3Kδ-Foxo1-FasL signaling amplification loop rewires CD4+ T cell signaling and differentiation (2026 · The Journal of Experimental Medicine · 被引 1)